Marvin S. Swartz, MD
- 5Articles
- 17.8KReads1
- 2004–2018Active
- 25Collaborators
- 95Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Marvin S. Swartz, MD, has published extensively on schizophrenia and schizoaffective disorders, major depressive disorder, and neurology. His work includes studies on the effects of long-acting injectable antipsychotics, the impact of second-generation antipsychotics and perphenazine on depressive symptoms in chronic schizophrenia, and treatment outcomes for tardive dyskinesia. He has also investigated medication adherence and long-term functional outcomes in schizophrenia, as well as strategies to reduce violence risk in this population. His research has appeared in Psychiatrist.com between 2004 and 2018.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
